Skip to main content
Log in

Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

In order to localise the often reported anxiolytic action of N-methyl-D-aspartate (NMDA) receptor antagonists, 2-amino-7-phosphonoheptanoic acid (AP7) was injected into the dorsal periaqueductal grey (DPAG) of rats exposed to the elevated plus-maze model of anxiety. Doses of 0.2, 2 and 20 nmol AP7 caused a dose-dependent increase in the percentage of open arm entries, the effect of the last two doses being significantly different from control. A non-significant tendency to increase the percentage of time spent on the open arms of the maze was also noticed. In contrast, the total number of entries into either the open or enclosed arms was not affected. Injections of AP7 localized outside the DPAG were ineffective. Therefore, microinjection of AP7 into the DPAG caused a selective anxiolytic effect in the elevated plusmaze. It may be suggested that the DPAG is a site of the anxiolytic action of NMDA antagonists reported following systemic administration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Audi EA, de Oliveira CE, Graeff FG (1989) Serotonergic mediation of the anxiolytic effect of intracerebrally injected propranolol measured in the elevated plus-maze. Braz J Med Biol Res 22:699–701

    Google Scholar 

  • Bandler R (1984) Identification of hypothalamic and midbrain periaqueductal grey neurones mediating aggressive and defensive behaviour by microinjections of excitatory aminoacids. In: Bandler R (ed) Modulation of sensorimotor activity during alterations in behavioral states. Liss, New York, pp 369–391

    Google Scholar 

  • Beart PM, Nicolopoulos LS, West DC, Headley PM (1988) An excitatory amino acid projection from ventromedial hypothalamus to periaqueductal gray in the rat: autoradiographic and electrophysiological evidence. Neurosci Lett 85:205–211

    Google Scholar 

  • Beitz AJ (1989) Possible origin of glutamatergic projections to the midbrain periaqueductal gray and deep layer of the superior colliculus of the rat. Brain Res Bull 23:25–35

    Google Scholar 

  • Bennett DA, Amrick CL (1986) 2-amino-7-phosphonoheptanoic acid (AP7) produces discriminative stimuli and anticonflict effects similar to diazepam. Life Sci 39:2455–2461

    Google Scholar 

  • Brandão ML, Fontes JCS, Graeff FG (1980) Facilitatory effect of ketamine on punished behavior. Pharmacol Biochem Behav 13:1–4

    Google Scholar 

  • Carobrez AP (1987) Excitatory amino acid mediation of the defence reaction. In: Brandão ML (ed) Neurosciences and behavior. UFES-Grafica, Vitória, Brazil, pp 21–29

    Google Scholar 

  • Cavalheiro EA, Lehman J, Turski L (1988) Frontiers in excitatory amino acid research. Liss, New York

    Google Scholar 

  • Clineschmidt B, Williams M, Witoslawski J, Bunting P, Risley A, Totaro J (1982) Restoration of shock-suppressed behavior by treatment with (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties. Drug Dev Res 2:147–163

    Google Scholar 

  • Graeff FG (1984) The anti-aversive action of minor tranquillizers. TIPS 5:230–233

    Google Scholar 

  • Graeff FG (1987) The antiaversive action of drugs. In: Thompson T, Dews PB, Barrett JE (eds) Neurobehavioral pharmacology. Lawrence Erlbaum, Hillsdale, New Jersey, pp 129–156

    Google Scholar 

  • Graeff FG (1988) Animal models of aversion. In: Simon P, Soubrié, Wiedlocher D (eds) Selected models of anxiety, depression and psychosis. Karger, Basel, pp 115–141

    Google Scholar 

  • Graeff FG (1990) Brain defence system and anxiety. In: Roth M, Burrows GD, Noyes R (eds) Handbook of anxiety, Vol 3. Elsevier, Amsterdam, pp 307–354

    Google Scholar 

  • Graeff FG, Brandão ML, Audi EA, Schütz MTB (1986) Modulation of the brain aversive system by GABAergic and serotonergic mechanisms. Behav Brain Res 21:65–72

    Google Scholar 

  • Graeff FG, Carobrez AP, Silveira MCL (1988) Excitatory amino acids and the brain aversive system. In: Cavalheiro EA, Lehman J, Turski L (eds) Frontiers in excitatory amino acid research. Liss, New York, pp 325–332

    Google Scholar 

  • König JFR, Klippel RA (1963) The rat brain in stereotaxic coordinates. Williams and Wilkins, Baltimore.

    Google Scholar 

  • Kostowski W, Plaznik A, Stefanski R (1989) Intra-hippocampal buspirone in animal models of anxiety. Eur J Pharmacol 168:393–396

    Google Scholar 

  • Krieger JE, Graeff FG (1985) Defensive behavior and hypertension induced by glutamate in the midbrain central gray of the rat. Braz J Med Biol Res 18:61–67

    Google Scholar 

  • Pellow S, Chopin P, File SE, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167

    Google Scholar 

  • Porter JH, Wiley JL, Balster RL (1989) Effects of phencyclidine-like drugs on punished behavior in rats J Pharmacol Exp Ther 248:997–1002

    Google Scholar 

  • Stephens DN, Meldrum BS, Weidmann R, Schneider C, Grutzner M (1986) Does the excitatory amino-acid receptor antagonist 2-APH exhibit anxiolytic activity? Psychopharmacology 90:166–169

    Google Scholar 

  • Wenger GR (1980) Effects of phencyclidine and ketamine in pigeons on behavior suppressed by brief electrical shocks. Pharmacol Biochem Behav 12:865–870

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guimarães, F.S., Carobrez, A.P., De Aguiar, J.C. et al. Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey. Psychopharmacology 103, 91–94 (1991). https://doi.org/10.1007/BF02244080

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02244080

Key words

Navigation